Dr. Brian Caveney discusses how Test Finder, a novel generative AI tool, can ease clinicians’ EHR burdens through enhanced ...

BURLINGTON, N.C., July 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its ...

BURLINGTON, N.C., July 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its ...

Access to rapidly developing diagnostic technology such as blood-based biomarkers for early detection and subsequent ...

To help facilitate more effective venom therapy, Labcorp, a leading global life sciences company, has launched its unique Labcorp Clinical Decision Support interpretative test report for its ...

Labcorp announced this week a new testing program that provides genomic insights for cancer patients that is sponsored by Eli Lilly and Company.

Launch and availability of the test demonstrates Labcorp’s commitment to neurology and to improving the health and lives of the millions afflicted by neurodegenerative and related diseases.

Labcorp will begin testing for monkeypox using the CDC's orthopoxvirus, becoming the first national laboratory to do so. The testing will be completed in Labcorp's main lab in North Carolina.

Life science giant LabCorp is rolling out a new test that the North Carolina-based conglomerate says will detect COVID-19 and influenza.

Labcorp’s Stinging Insect Component-Specific IgE Testing helps identify the specific venom to which the patient is allergic and provides a more precise diagnosis to support venom immunotherapy.